Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countries.
Saleem Z. et al, (2025), JAC Antimicrob Resist, 7
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications.
Saleem Z. et al, (2025), Expert review of anti-infective therapy
A pilot protocol for surveillance of infection and antibiotic prescribing in primary healthcare across the globe: Antibiotic Prescribing in Primary Healthcare Point Prevalence Survey (APC-PPS)
Cook A. et al, (2025), Wellcome Open Research, 10, 26 - 26
Knocking Out Antimicrobial Resistance editorial: reflections on the United Nations General Assembly high-level meeting on antimicrobial resistance
Moore CE. and Joshi LT., (2024), Journal of Medical Microbiology, 73
Identifying AWaRe indicators for appropriate antibiotic use: a narrative review
Funiciello E. et al, (2024), Journal of Antimicrobial Chemotherapy
Knocking Out AMR project review
Joshi LT. and Moore CE., (2024), Journal of Medical Microbiology, 73
Advancing global antibiotic research, development and access
Piddock LJV. et al, (2024), Nature Medicine
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Naghavi M. et al, (2024), The Lancet Infectious Diseases, 24, 868 - 895
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
Ledesma JR. et al, (2024), The Lancet Infectious Diseases, 24, 698 - 725
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Brauer M. et al, (2024), The Lancet, 403, 2162 - 2203
Implementation of an antibiotic resistance surveillance tool in Madagascar, the TSARA project: a prospective, observational, multicentre, hospital-based study protocol
Elias C. et al, (2024), BMJ Open, 14, e078504 - e078504
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis
Sartorius B. et al, (2024), The Lancet Global Health, 12, e201 - e216
Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral Hospital.
Sinto R. et al, (2024), PloS one, 19
Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group
Baker KS. et al, (2023), The Lancet Microbe, 4, e1035 - e1039
Genomics for antimicrobial resistance surveillance to support infection prevention and control in health-care facilities
Jauneikaite E. et al, (2023), The Lancet Microbe, 4, e1040 - e1046
Genomics for public health and international surveillance of antimicrobial resistance
Baker KS. et al, (2023), The Lancet Microbe, 4, e1047 - e1055
Innovations in genomic antimicrobial resistance surveillance
Wheeler NE. et al, (2023), The Lancet Microbe, 4, e1063 - e1070
Current rates of purchasing of antibiotics without a prescription across sub-saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance.
Sono TM. et al, (2023), Expert Rev Anti Infect Ther
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis
Aguilar GR. et al, (2023), The Lancet Regional Health - Americas, 25, 100561 - 100561